Apellis Pharmaceuticals (APLS) - Management Comments

Apellis Pharmaceuticals (APLS) – Management Comments

Aug 22, 2023 04:43 PM Apellis Pharmaceuticals (APLS) Provides Updates on Injection Kits and Rare Safety Events with SYFOVRE
May 25, 2021 07:01 AM Apellis Pharmaceuticals (APLS) and Swedish Orphan Biovitrum Reports Positive Top-line Results from the Phase 3 PRINCE Study of EMPAVELI (pegcetacoplan)
Apr 13, 2021 07:01 AM
Mar 18, 2021 06:44 AM
Nov 19, 2020 06:53 AM
Nov 16, 2020 07:05 AM
Oct 27, 2020 07:08 AM
Oct 19, 2020 07:03 AM
Sep 15, 2020 07:06 AM
Jul 7, 2020 07:01 AM
Jul 2, 2020 08:02 AM
Jun 12, 2020 06:03 AM
May 21, 2020 07:08 AM
Apr 28, 2020 07:15 AM
Apr 6, 2020 08:04 AM
Sep 18, 2019 08:03 AM
Sep 3, 2019 08:05 AM
Jun 27, 2019 07:43 AM
Jun 17, 2019 05:47 AM
Mar 4, 2019 07:11 AM
Feb 28, 2019 10:02 AM
Feb 11, 2019 07:10 AM
Feb 5, 2019 12:03 PM
Dec 20, 2018 04:02 PM
Dec 20, 2018 07:03 AM
Dec 3, 2018 01:04 PM
Sep 12, 2018 07:31 AM
Sep 4, 2018 07:33 AM
Jul 24, 2018 09:04 AM
Jun 26, 2018 07:34 AM
Apr 16, 2018 09:26 AM
Feb 22, 2018 08:48 AM
Dec 20, 2017 05:31 PM
Dec 19, 2017 10:17 AM